Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 28;11(19):5746.
doi: 10.3390/jcm11195746.

Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease

Affiliations

Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease

Dimitra Bacharaki et al. J Clin Med. .

Abstract

Introduction. The aim of the study was to examine the impact of adherence to a Mediterranean-style diet (MD) on left ventricular hypertrophy (LVH) and cardiac geometry in chronic kidney disease patients on dialysis (CKD-5D), given the high prevalence of cardiovascular morbidity in this population. Methods. n = 127 (77 men and 50 women) CKD-5D patients (69 on hemodialysis and 58 on peritoneal dialysis) with a mean age of 62 ± 15 years were studied. An MD adherence score (MDS) (range 0−55, 55 representing maximal adherence) was estimated with a validated method. Echocardiographic LVH was defined by LV mass index (LVMI) > 95 g/m2 in women and >115 g/m2 in men. Based on LVMI and relative wall thickness (RWT), four LV geometric patterns were defined: normal (normal LVMI and RWT), concentric remodeling (normal LVMI and increased RWT > 0.42), eccentric LVH (increased LVMI and normal RWT), and concentric LVH (increased LVMI and RWT). Results. Patients with LVH (n = 81) as compared to patients with no LVH (n = 46) were older in age (66 ± 13 vs. 55 ± 16 years; p < 0.001) had lower MDS (24 ± 2.7 vs. 25 ± 4.3; p < 0.05) and higher malnutrition-inflammation score (5.0 ± 2.7 vs. 3.9 ± 1.9; p < 0.05), body mass index (27.5 ± 4.9 vs. 24.1 ± 3.5 kg/m2; p < 0.001), prevalence of diabetes (79% vs. 20%; p < 0.05), coronary artery disease (78% vs. 20%; p < 0.05) and peripheral vascular disease (78% vs. 20%; p < 0.01). In a multivariate logistic regression analysis adjusted for all factors mentioned above, each 1-point greater MDS was associated with 18% lower odds of having LVH (OR = 0.82, 95% CI: 0.69−0.98; p < 0.05). MDS was inversely related to LVMI (r = −0.273; p = 0.02), and in a multiple linear regression model (where LVMI was analyzed as a continuous variable), MDS emerged as a significant (Β = −2.217; p < 0.01) independent predictor of LVH. Considering LV geometry, there was a progressive decrease in MDS from the normal group (25.0 ± 3.7) to concentric remodeling (25.8 ± 3.0), eccentric (24.0 ± 2.8), and then concentric (23.6 ± 2.7) group (p < 0.05 for the trend). Conclusions. The greater adherence to an MD is associated with lesser LVH, an important cardiovascular disease risk factor; MD preserves normal cardiac geometry and may confer protection against future cardiac dysfunction in dialysis patients.

Keywords: Mediterranean diet; cardiac geometry; end-stage kidney disease; left ventricular hypertrophy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interest.

Figures

Figure 1
Figure 1
The correlation between left ventricular mass index (LVMI) and Mediterranean diet score (MDS); HD, Hemodialysis; PD, Peritoneal Dialysis.
Figure 2
Figure 2
Distribution of cardiac geometry patterns (n = 127 chronic kidney disease patients on dialysis).
Figure 3
Figure 3
Mediterranean diet score (MDS) by left ventricular geometry patterns.

References

    1. Mafham M., Emberson J., Landray M.J., Wen C.-P., Baigent C. Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis. PLoS ONE. 2011;6:e25920. doi: 10.1371/journal.pone.0025920. - DOI - PMC - PubMed
    1. Lindner A., Charra B., Sherrard D.J., Scribner B.H. Accelerated Atherosclerosis in Prolonged Maintenance Hemodialysis. N. Engl. J. Med. 1974;290:697–701. doi: 10.1056/NEJM197403282901301. - DOI - PubMed
    1. Krediet R.T., Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat. Rev. Nephrol. 2010;6:451–460. doi: 10.1038/nrneph.2010.68. - DOI - PubMed
    1. Staplin N., Haynes R., Herrington W.G., Reith C., Cass A., Fellström B., Jiang L., Kasiske B.L., Krane V., Levin A., et al. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP) Am. J. Kidney Dis. 2016;68:371–380. doi: 10.1053/j.ajkd.2016.02.052. - DOI - PMC - PubMed
    1. Prospective Studies Collaboration. Whitlock G., Lewington S., Sherliker P., Clarke R., Emberson J., Halsey J., Qizilbash N., Collins R., Peto R. Body-mass index and cause-specific mortality in 900,000 adults: Collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–1096. doi: 10.1016/s0140-6736(09)60318-4. - DOI - PMC - PubMed